Chondroitin for Osteoarthritis of the Knee or Hip

  1. Sven Trelle, MD;
  2. Stephan Reichenbach, MD; and
  3. Peter Jüni, MD
  1. From University of Bern, 3012 Bern, Switzerland.

    IN RESPONSE:

    As correctly pointed out by Dr. Goldberg and colleagues, our meta-analysis was hampered by the limited quality of included trials and the heterogeneity of their results. Therefore, the interpretation of the meta-analysis of all trials was difficult and the investigation of potential sources of heterogeneity mandatory (1). The restriction of the analysis to large-scale, high-quality trials covering 40% of patients was not based on subjective judgment, but on results from stratified analyses and corresponding interaction tests. All explored factors were prespecified before initiating our systematic review. The 3 factors associated with treatment effects—concealment of allocation, intention-to-treat analysis, and …

    Related Article

    « Previous | Next Article »Table of Contents